BRIEF-T. Rowe Price Associates Reports 11.7 Pct Passive Stake In Alnylam Pharmaceuticals
December 11, 2017 at 14:40 PM EST
* T. ROWE PRICE ASSOCIATES INC REPORTS 11.7 PERCENT PASSIVE STAKE IN ALNYLAM PHARMACEUTICALS INC AS OF NOVEMBER 30 - SEC FILING Source text : http://bit.ly/2ALIqHV Further company coverage:
